End-stage Renal Failure (ESRF)

DBCOND0075578Urogenital Diseases

End-stage Renal Failure (ESRF) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
End-Stage Renal Failure · Renal Failure, End Stage · End Stage Renal Failure · Renal Failure, End-Stage · End-stage Kidney Failure
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT023061ICD-10N18SNOMED CT155856009MedDRA10009119UMLSC0022661

What you can answer from here — as of September 30, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
35Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for End-stage Renal Failure (ESRF) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In